Sam Behjati MA, BMBCh (Oxon), PhD, MRCPCH

Dr. Behjati is a Group Leader at the Wellcome Sanger Institute and Consultant Paediatric Oncologist at Addenbrooke’s Hospital, Cambridge. His research is focused on unraveling the origins of cancer, using a variety of cutting-edge nucleic acid sequencing technologies. Previously he has defined the somatic genetic basis of different subtypes of sarcoma, as part of the UK contribution to the International Cancer Genome Consortium. He continues to pursue his interest in sarcoma genomics through the Genomics England sarcoma program and his own research. Dr. Behjati read medicine at the University of Oxford and pursued clinical academic training in pediatric oncology in London and Cambridge.